Teladoc Health, INC Form 4 insider transactions

Mark Anquillare V, a Director of Teladoc Health, Inc., received 37,425 shares of common stock on August 3, 2026.

Teladoc Health, Inc. reports a Form 4 filing detailing a stock transaction by Kelly Bliss, President of U.S. Group Health, executed under a pre-arranged trading plan.

Joseph Catapano, Chief Accounting Officer at Teladoc Health, reported transactions involving restricted stock units and common stock sales.

Teladoc Health, Inc. reports a transaction where President of U.S. Group Health, Kelly Bliss, sold 2,500 shares of common stock on July 1, 2026, as part of a pre-arranged 10b5-1 trading plan.

Teladoc Health's President of U.S. Group Health, Kelly Bliss, has sold 2,500 shares of common stock as part of a pre-arranged trading plan.

Teladoc Health CEO Charles Divita acquired 42,802 shares via equity vesting and sold 18,074 shares to cover tax obligations.

Fernando M. Rodrigues, President of BetterHelp at Teladoc Health, Inc., reported a sale of 9,572 shares of common stock executed on June 3, 2026, under a pre-arranged Rule 10b5-1 trading plan.

Fernando Rodrigues, President of BetterHelp, reported transactions involving Teladoc Health, Inc. common stock and restricted stock units.

Adam C. Vandervoort, Chief Legal Officer of Teladoc Health, Inc., reported transactions involving the acquisition and disposition of company stock.

Carlos Nueno, President of International at Teladoc Health, reported transactions involving restricted stock units and common stock.

Teladoc Health CEO Charles Divita III sold shares to cover tax obligations related to vesting stock units, impacting his beneficial ownership.

Joseph Ronald Catapano, Chief Accounting Officer at Teladoc Health, Inc., reported transactions involving common stock, including the acquisition of performance and restricted stock units and the sale of shares to cover tax obligations.

Kelly Bliss, President of Teladoc Health's U.S. Group Health, reported transactions involving the sale of common stock to cover tax withholding obligations.

Director Mark Douglas Smith was granted 30,441 restricted stock units by Teladoc Health, Inc. on May 21, 2026.

Teladoc Health director Kenneth H. Paulus was granted 30,441 restricted stock units as part of his director compensation.

Teladoc Health director Sandra Fenwick was granted 30,441 restricted stock units as part of annual director compensation.

Teladoc Health director David Shedlarz acquired 29,986 shares via RSU vesting and was granted 30,441 new restricted stock units.

Director Catherine Jacobson acquired 28,986 shares via RSU vesting and was granted 30,441 new restricted stock units.

Director David B. Snow Jr. acquired 28,986 shares of Teladoc Health common stock via restricted stock unit vesting and was granted 30,441 new units.

Teladoc Health's Chief Accounting Officer, Joseph Ronald Catapano, reported transactions involving restricted stock units and common stock sales.

Teladoc Health, Inc. Director Susan R. Salka was granted 48,638 restricted stock units, aligning her interests with long-term shareholder value.

Teladoc Health, Inc. filed an amended Form 4 to correct the number of performance stock units awarded to President Kelly Bliss.

Teladoc Health's Chief Legal Officer, Adam C. Vandervoort, reported the vesting and acquisition of restricted and performance stock units, alongside a sale of shares to cover tax obligations.

Teladoc Health CEO Charles Divita III reported the conversion of restricted and performance stock units and the sale of shares to cover tax withholding obligations.

Kelly Bliss, President of U.S. Group Health at Teladoc Health, reported the vesting of equity awards and a subsequent sale of shares to cover tax withholding obligations.

Teladoc Health Director Michael S. Smith received a grant of 53,648 restricted stock units, aligning his interests with shareholders.

Teladoc Health's Chief Accounting Officer, Joseph Ronald Catapano, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax withholding.

Teladoc Health Director Jason Eric Evans converted 1,016 restricted stock units into common stock on December 19, 2025, increasing his direct beneficial ownership.

Teladoc Health CEO Charles Divita III reported the vesting of restricted stock units and the subsequent sale of shares to cover tax obligations.

Teladoc Health's BetterHelp President, Fernando M. Rodrigues, sold shares following RSU vesting under a pre-arranged trading plan.